PEAK6 Investments’s Integra LifeSciences IART Stock Holding History

PEAK6 Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-40,100	Closed	-$1.17M	–	3738
2024 Q2	$1.17M	Buy	+40,100	New	+$1.19M	﹤0.01%	1713
2024 Q1	–	Sell	-3,300	Closed	-$144K	–	4320
2023 Q4	$144K	Buy	+3,300	New	+$130K	﹤0.01%	3410
2021 Q1	–	Sell	-9,400	Closed	-$610K	–	5161
2020 Q4	$610K	Buy	9,400 +1,600	+21%	+$86.1K	﹤0.01%	2923
2020 Q3	$368K	Sell	7,800 -7,800	-50%	-$371K	﹤0.01%	3078
2020 Q2	$733K	Buy	+15,600	New	+$767K	﹤0.01%	2362
2019 Q4	–	Sell	-75,000	Closed	-$4.5M	–	3689
2019 Q3	$4.5M	Sell	75,000 -7,400	-9%	-$441K	0.03%	729
2019 Q2	$4.6M	Sell	82,400 -30,000	-27%	-$1.54M	0.03%	755
2019 Q1	$6.26M	Buy	+112,400	New	+$5.72M	0.04%	579
2018 Q4	–	Sell	-92,200	Closed	-$6.07M	–	4277
2018 Q3	$6.07M	Buy	+92,200	New	+$5.73M	0.03%	689

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Investments's IART Position: Q3 2024 in Review

PEAK6 Investments sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 3,653 shares — an estimated $106K sold.

PEAK6 Investments first reported a position in IART in Q3 2018 and held it in 11 quarters. The position peaked at $4.16M in Q3 2018. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

PEAK6 Investments reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
PEAK6 Investments sold 3,653 Integra LifeSciences shares in Q3 2024, an estimated $106K.
PEAK6 Investments first reported a position in Integra LifeSciences in Q3 2018 and held it in 11 quarters.
PEAK6 Investments's Integra LifeSciences position peaked at $4.16M in Q3 2018.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.